Ianalumab

未知生产厂商

Ianalumab is under investigation in clinical trial NCT01930175 (Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris).

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Ianalumab is under investigation in clinical trial NCT01930175 (Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris).

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

TREATMENT FOR SJÖGREN'S SYNDROME
EP 4055047 A1申请人: NOVARTIS AG优先权: 2019
EP
US
WO
3 件公开
TREATMENT OF AIHA WITH BAFF OR BAFF RECEPTOR INHIBITORY ANTIBODIES
EP 4558522 A1申请人: NOVARTIS AG优先权: 2022
EP
US
WO
3 件公开
TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS USING ANTI-BAFFR ANTIBODIES
US 2024228644 A1申请人: NOVARTIS AG优先权: 2022
US